Karo Pharma AB Logo

Karo Pharma AB

KARO | ST

Overview

Corporate Details

ISIN(s):
NO0010308240 (+4 more)
LEI:
213800G54Z51LOPGTA79
Country:
Sweden
Address:
BOX 16184, 103 24 STOCKHOLM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Karo Healthcare AB, formerly Karo Pharma AB, is a healthcare company focused on providing consumer products for everyday health. The company owns and commercializes a portfolio of branded over-the-counter (OTC) products and prescription medicines across categories such as skin health, foot health, intimate health, and digestive health. Its mission is to empower individuals to make 'smart choices for everyday healthcare,' helping to prevent illness and treat common health problems. With a strong presence in Europe and the Nordic region, Karo Healthcare's products are available in over 90 countries worldwide.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Karo Pharma AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-05-31 16:00
Post-Annual General Meeting Information
Kommuniké från Karo Pharmas årsstämma 2022
Swedish 1.4 MB
2022-05-27 16:00
Pre-Annual General Meeting Information
Ändringar i Karo Intressenter AB:s förslag avseende val av styrelse till Karo P…
Swedish 1.1 MB
2022-05-02 18:30
Pre-Annual General Meeting Information
KALLELSE TILL ÅRSSTÄMMA I KARO PHARMA AKTIEBOLAG
Swedish 4.9 MB
2022-04-19 08:30
Share Issue/Capital Change
Karo Pharmas företrädesemission fulltecknad
Swedish 3.6 MB
2022-04-19 08:30
Share Issue/Capital Change
Karo Pharma’s rights issue fully subscribed
English 3.6 MB
2022-04-01 13:30
M&A Activity
Karo Pharma slutför förvärvet av E45® från Reckitt
Swedish 21.3 KB
2022-04-01 13:30
M&A Activity
Karo Pharma completes the acquisition of the E45® brand from Reckitt
English 46.1 KB
2022-03-23 12:00
Delisting Announcement
Karo Pharma offentliggör prospekt avseende företrädesemissionen och erhåller go…
Swedish 460.3 KB
2022-03-23 12:00
Report Publication Announcement
Karo Pharma publishes prospectus relating to the rights issue and receives appr…
English 438.3 KB
2022-03-16 08:00
Share Issue/Capital Change
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2.…
English 156.1 KB
2022-03-16 08:00
Share Issue/Capital Change
Karo Pharma beslutar om en fullt garanterad företrädesemission om cirka 2,5 mil…
Swedish 156.3 KB
2022-03-10 14:00
Delisting Announcement
Karo Pharma receives approval to delist the Company’s share from Nasdaq Stockho…
English 697.2 KB
2022-03-10 14:00
Delisting Announcement
Karo Pharma erhåller villkorat godkännande om avnotering av Bolagets aktier frå…
Swedish 696.0 KB
2022-03-09 12:00
Delisting Announcement
Karo Pharma applies for delisting of the Company’s shares from Nasdaq Stockholm…
English 51.0 KB
2022-03-09 12:00
Delisting Announcement
Karo Pharma ansöker om avnotering av Bolagets aktier från Nasdaq Stockholm i sa…
Swedish 51.7 KB

Automate Your Workflow. Get a real-time feed of all Karo Pharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Karo Pharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Antibiotice S.A. Logo
Manufactures FDA-approved generic drugs, sterile injectables, and APIs for global markets.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
Japan 4886
Astellas Pharma Inc. Logo Japan 4503
AstraZeneca PLC Logo
A global biopharma firm developing medicines for oncology, rare diseases, and biopharmaceuticals.
United Kingdom AZN
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland BANB